These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 2609919

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysis.
    Morgan RJ, Newman EM, Doroshow JH, McGonigle K, Margolin K, Raschko J, Chow W, Somlo G, Leong L, Tetef M, Shibata S, Hamasaki V, Carroll M, Vasilev S, Akman S, Coluzzi P, Wagman L, Longmate J, Paz B, Yen Y, Klevecz R.
    Cancer Res; 1998 Jul 01; 58(13):2793-800. PubMed ID: 9661893
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection.
    Howell SB, Pfeifle CE, Wung WE, Olshen RA.
    Cancer Res; 1983 Mar 01; 43(3):1426-31. PubMed ID: 6681730
    [Abstract] [Full Text] [Related]

  • 5. [Pharmacokinetic study of intraperitoneal chemotherapy with high-dose cisplatin for advanced ovarian cancer].
    Deng C, Huang R, Lian L.
    Zhonghua Fu Chan Ke Za Zhi; 1996 Mar 01; 31(3):159-62. PubMed ID: 8758790
    [Abstract] [Full Text] [Related]

  • 6. Intraperitoneal high-dose cisplatin and etoposide with systemic thiosulfate protection in second-line treatment of advanced ovarian cancer.
    Malmström H, Rasmussen S, Simonsen E.
    Gynecol Oncol; 1993 May 01; 49(2):166-71. PubMed ID: 8504983
    [Abstract] [Full Text] [Related]

  • 7. High-intensity intravenous cyclophosphamide and cisplatin, interim surgical debulking, and intraperitoneal cisplatin in advanced ovarian carcinoma: a pilot trial with ten-year follow-up.
    Shapiro F, Schneider J, Markman M, Reichman BS, Venkatraman E, Barakat R, Almadrones L, Spriggs D.
    Gynecol Oncol; 1997 Oct 01; 67(1):39-45. PubMed ID: 9345354
    [Abstract] [Full Text] [Related]

  • 8. Intraperitoneal cisplatin with systemic thiosulfate protection.
    Howell SB, Pfeifle CL, Wung WE, Olshen RA, Lucas WE, Yon JL, Green M.
    Ann Intern Med; 1982 Dec 01; 97(6):845-51. PubMed ID: 6890785
    [Abstract] [Full Text] [Related]

  • 9. [Intraperitoneal administration of cis-diamminedichloroplatinum (II) for peritoneal carcinomatosis caused by gastric cancers].
    Kurihara N, Kumai K, Kubota T, Furukawa T, Yamamoto T, Shimada A, Shibata S, Saikawa Y, Ogawa S, Murayama Y.
    Gan To Kagaku Ryoho; 1993 Aug 01; 20(11):1645-8. PubMed ID: 8373238
    [Abstract] [Full Text] [Related]

  • 10. Phase I/pharmacokinetic study of intraperitoneal cisplatin and etoposide.
    Zimm S, Cleary SM, Lucas WE, Weiss RJ, Markman M, Andrews PA, Schiefer MA, Kim S, Horton C, Howell SB.
    Cancer Res; 1987 Mar 15; 47(6):1712-6. PubMed ID: 3815369
    [Abstract] [Full Text] [Related]

  • 11. 'Two-route chemotherapy' using cisplatin and its neutralizing agent, sodium thiosulfate, for intraperitoneal cancer.
    Abe R, Akiyoshi T, Baba T.
    Oncology; 1990 Mar 15; 47(5):422-6. PubMed ID: 2216298
    [Abstract] [Full Text] [Related]

  • 12. A phase I trial of intravenous melphalan, paclitaxel, and cisplatin plus granulocyte-colony stimulating factor in patients with suboptimal advanced epithelial ovarian carcinoma or peritoneal carcinoma.
    Gershenson DM, Morris M, Burke TW, Levenback C, Wolf J, Lee JJ, Thall PF, Atkinson EN, Silva EG, Wharton JT.
    Cancer; 1999 Dec 01; 86(11):2291-300. PubMed ID: 10590370
    [Abstract] [Full Text] [Related]

  • 13. Feasibility of using intraperitoneal epinephrine and cisplatin in patients with advanced peritoneal carcinomatosis.
    Molucon-Chabrot C, Isambert N, Benoit L, Zanetta S, Fraisse J, Guilland JC, Royer B, Monin-Baroille P, Flesch M, Fargeot P, Coudert B, Mayer F, Fumoleau P, Chauffert B.
    Anticancer Drugs; 2006 Nov 01; 17(10):1211-7. PubMed ID: 17075321
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The clinical and pharmacokinetic evaluation of two-route chemotherapy with cisplatin and sodium thiosulfate in combination with angiotensin II].
    Takizawa K, Harada M, Fujimaru J, Matsushiro N, Shima Y, Andoh I, Satoh M, Yokoo I, Iguchi T, Hirabayashi K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 May 01; 44(5):595-602. PubMed ID: 1619320
    [Abstract] [Full Text] [Related]

  • 16. [Intraperitoneal versus intravenous infusion of cis-platinum in advanced ovarian cancer--examination of pharmacokinetics].
    Shindo K, Oikawa N, Atsumi Y, Chida S, Tuburaya T, Yajima A.
    Gan To Kagaku Ryoho; 1987 Mar 01; 14(3 Pt 1):639-44. PubMed ID: 3827260
    [Abstract] [Full Text] [Related]

  • 17. Phase III randomized trial of intravenous cisplatin plus a 24- or 96-hour infusion of paclitaxel in epithelial ovarian cancer: a Gynecologic Oncology Group Study.
    Spriggs DR, Brady MF, Vaccarello L, Clarke-Pearson DL, Burger RA, Mannel R, Boggess JF, Lee RB, Hanly M.
    J Clin Oncol; 2007 Oct 01; 25(28):4466-71. PubMed ID: 17906207
    [Abstract] [Full Text] [Related]

  • 18. Hexamethylmelamine and cisplatin in advanced ovarian cancer after failure of alkylating-agent therapy.
    Vogl SE, Pagano M, Davis TE, Einhorn N, Tunca JC, Kaplan BH, Arseneau JC.
    Cancer Treat Rep; 1982 Jun 01; 66(6):1285-90. PubMed ID: 6282454
    [Abstract] [Full Text] [Related]

  • 19. Dose-escalated paclitaxel in 1-hour infusion with a fixed dose of cisplatin in previously untreated advanced ovarian cancer: a phase II trial of the Spanish Group for Ovarian Cancer.
    Cervantes A, Mendiola C, del Campo JM, Massuti B, Casado A, Escobedo A, Moyano A, Ojeda B, Poveda A, Benito D.
    Semin Oncol; 1997 Oct 01; 24(5 Suppl 15):S15-40-S15-43. PubMed ID: 9346221
    [Abstract] [Full Text] [Related]

  • 20. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
    Belli L, LeChevalier T, Gottfried M, Adams D, Ruffie P, LeCesne A, Tete L, Pellae-Cosset B.
    Semin Oncol; 1995 Dec 01; 22(6 Suppl 15):29-33. PubMed ID: 8643967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.